371 related articles for article (PubMed ID: 29877858)
1. Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management.
Soni A; Gowthamarajan K; Radhakrishnan A
Int J Pharm Compd; 2018; 22(2):108-121. PubMed ID: 29877858
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
[TBL] [Abstract][Full Text] [Related]
3. Role of Proteomics in the Development of Personalized Medicine.
Jain KK
Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
[TBL] [Abstract][Full Text] [Related]
4. Theoretical Formulation Strategies towards Neutralizing Inter-individual Variability Associated with Tacrolimus Immunosuppressant Therapy: A Case Study on Nextgeneration Personalized Medicine.
Radhakrishnan A; Kuppusamy G
Curr Drug Metab; 2021; 22(12):939-956. PubMed ID: 34779367
[TBL] [Abstract][Full Text] [Related]
5. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine: genetic component to providing quality care.
Kaldy J
Consult Pharm; 2011 Sep; 26(9):618-27. PubMed ID: 21896469
[TBL] [Abstract][Full Text] [Related]
7. What's in a word? The person of personalized (nano)medicine.
Guchet X
Nanomedicine (Lond); 2015; 10(20):3167-79. PubMed ID: 26446343
[TBL] [Abstract][Full Text] [Related]
8. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
9. Role of nanobiotechnology in developing personalized medicine for cancer.
Jain KK
Technol Cancer Res Treat; 2005 Dec; 4(6):645-50. PubMed ID: 16292884
[TBL] [Abstract][Full Text] [Related]
10. Cancer genomics guide clinical practice in personalized medicine.
Lehmann-Che J; Poirot B; Boyer JC; Evrard A
Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
[TBL] [Abstract][Full Text] [Related]
11. "
Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
[TBL] [Abstract][Full Text] [Related]
12. Personalized Management of Cardiovascular Disorders.
Jain KK
Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
[TBL] [Abstract][Full Text] [Related]
13. Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy.
Jhawat V; Gulia M; Gupta S; Maddiboyina B; Dutt R
J Control Release; 2020 Nov; 327():500-511. PubMed ID: 32858073
[TBL] [Abstract][Full Text] [Related]
14. Towards next-generation personalization of tacrolimus treatment: a review on advanced diagnostic and therapeutic approaches.
Radhakrishnan A; Kuppusamy G; Ponnusankar S; Mutalik S
Pharmacogenomics; 2021 Nov; 22(17):1151-1175. PubMed ID: 34719935
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
[TBL] [Abstract][Full Text] [Related]
16. Future of personalized medicine in oncology: a systems biology approach.
Gonzalez-Angulo AM; Hennessy BT; Mills GB
J Clin Oncol; 2010 Jun; 28(16):2777-83. PubMed ID: 20406928
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska A; Frantzi M; Vlahou A; Merseburger AS; Mischak H
Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 28980455
[TBL] [Abstract][Full Text] [Related]
19. Personalized medicine. Closing the gap between knowledge and clinical practice.
Anaya JM; Duarte-Rey C; Sarmiento-Monroy JC; Bardey D; Castiblanco J; Rojas-Villarraga A
Autoimmun Rev; 2016 Aug; 15(8):833-42. PubMed ID: 27302209
[TBL] [Abstract][Full Text] [Related]
20. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
Basu B; Basu S
Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
